BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26226911)

  • 21. Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer.
    Kaufman HL; Harandi A; Watson MC; Carter EL; DeRaffele G; Shahid M; Fine RL
    Lancet Oncol; 2005 Jan; 6(1):62-3. PubMed ID: 15629278
    [No Abstract]   [Full Text] [Related]  

  • 22. Pancreatic cancer symposium: epidemiology, etiology, pathogenesis, and therapy.
    Wanebo HJ; Glicksman AS; Clark JW
    Pancreas; 1995 Apr; 10(3):217-21. PubMed ID: 7624298
    [No Abstract]   [Full Text] [Related]  

  • 23. [Management of endocrine pancreatic tumors].
    Schöber C; Galanski M; Jörgensen M; Schmoll HJ
    Wien Med Wochenschr; 1997; 147(1):18-23. PubMed ID: 9133102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic imaging and combined modality therapy of the cancer of the pancreatic head area.
    Marano P
    Rays; 1995; 20(3):223-5. PubMed ID: 8559965
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant therapy for pancreatic cancer: current status and future directions.
    Xiong HQ; Abbruzzese JL
    Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Malignant tumors of the exocrine pancreas. Strategies of treatment].
    Marrano D
    Minerva Chir; 1989 Jan; 44(1-2):183-5. PubMed ID: 2710379
    [No Abstract]   [Full Text] [Related]  

  • 27. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer?
    Pisters PW; Evans DB
    Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622
    [No Abstract]   [Full Text] [Related]  

  • 28. [Current strategy to cure pancreatic cancer].
    Tanaka M
    Nihon Geka Gakkai Zasshi; 2002 Mar; 103(3):290-3. PubMed ID: 11968759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Supportive therapy of pancreatic carcinoma].
    Hentschel E; Meryn S
    Wien Klin Wochenschr; 1994; 106(22):701-3. PubMed ID: 7529956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recent advances in combined therapy with surgery for pancreatic cancer].
    Hosotani R
    Nihon Geka Hokan; 1995 Mar; 64(2):43-4. PubMed ID: 8678722
    [No Abstract]   [Full Text] [Related]  

  • 31. [XXVII session of the European Pancreatic Club, Barcelona, 28 June-1 July, 1995].
    Jurkowska G; Rydzewska G
    Pol Arch Med Wewn; 1995 Oct; 94(4):375-81. PubMed ID: 8834134
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer.
    Morak MJ; Richel DJ; van Eijck CH; Nuyttens JJ; van der Gaast A; Vervenne WL; Padmos EE; Schaake EE; Busch OR; van Tienhoven G
    Radiother Oncol; 2011 Feb; 98(2):261-4. PubMed ID: 21075468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenocarcinoma of the pancreas--past, present and future.
    Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
    Hepatogastroenterology; 2005; 52(64):1281-92. PubMed ID: 16001679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary pancreatic lymphoma. A report of five cases.
    Arcari A; Anselmi E; Bernuzzi P; Berta R; Lazzaro A; Moroni CF; Trabacchi E; Vallisa D; Vercelli A; Cavanna L
    Haematologica; 2005 Jan; 90(1):ECR09. PubMed ID: 16791931
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term survival following postoperative combined modality therapy for pancreatic cancer].
    Miyazawa K; Yoshioka S; Shiobara M; Wakatsuki K; Kataoka M; Arai S; Yamazaki K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2190-2. PubMed ID: 25731466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Locally advanced pancreatic cancer: current therapeutic approach.
    Cardenes HR; Chiorean EG; Dewitt J; Schmidt M; Loehrer P
    Oncologist; 2006 Jun; 11(6):612-23. PubMed ID: 16794240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multidisciplinary therapy for recurrent pancreatic cancer].
    Morimoto O; Senzai M; Mori S; Takiuchi D; Adachi S; Azama T; Hirao T; Ota H; Kitada M; Shibata K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2172-4. PubMed ID: 25731460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment and present status of pancreatic cancer].
    Onoyama H; Kamigaki T; Yamamoto M; Saitoh Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2304-10. PubMed ID: 1463335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates and controversies in the treatment of pancreatic cancer.
    Kosuri K; Muscarella P; Bekaii-Saab TS
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):47-54. PubMed ID: 16562370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Present status and progress in diagnosis of and therapy for pancreatic disease (discussion)].
    Saisho H; Kawa S; Minami K; Ono I; Funakoshi A
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):108-27. PubMed ID: 14968583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.